Thus, YG exerted neuroprotective effects by activating ERK/CREB/BDNF signaling in the hippocampus, indicating its potential cognition-enhancing effects, especially in Alzheimer’s disease. The gene discussed is CREB1; the disease is early-onset autosomal dominant Alzheimer disease.